Interactive Dreaming May Hold Similar Therapeutic Potential As Psychedelics
ResearchInteractive or lucid dreaming may be as beneficial for mental health as lucid dreaming, new research finds.
New Study Will Look At Ibogaine Treatment for Opioid Addiction
ResearchA potent tool in the battle against opioid addiction, ibogaine treatment is the subject of a new study in the UK.
Psilocybin’s Relationship with Creativity a ‘Complicated’ Affair, Study Finds
ResearchNew research points to a connection between psilocybin mushrooms and creativity.
Psilocybin As Effective as Lexapro in Treating Depression: Study
ResearchThe first study of its kind compares psilocybin and the antidepressant Lexapro in treating depression. The results are promising.
Lower Doses of Psilocybin May Still Have Antidepressant Effects
ResearchPsilocybin taken at low doses could have powerful antidepressant effects, according to new research findings.
Ketamine Therapy Shows Benefits in Treating Depression Related to Childhood Abuse
Research, Treatment
Adults with depression who were abused or neglected as children responded better to intravenous ketamine therapy than depressed adults who were not mistreated, according to a poster presentation and discussion at the recent Anxiety and Depression…
The Company of Others: How Shared Psychedelic Experiences Influence Outcomes
Research, TreatmentDoes taking psychedelics with others improve the experiences for all individuals? Researchers are looking at the benefits.
Yale to Study Psilocybin for Cluster Headaches
ResearchPsilocybin is showing relief as treatment for cluster headaches — a painful condition that affects more than 300,000 Americans a year.
Study Investigates Optimal Dosing for MDMA
ResearchPotential optimal MDMA dosages for therapeutic benefit and reduced adverse events were investigated in a new study published in the latest edition of the Journal of Psychopharmacology.
UCSF Launches New Psychedelic Research Division
ResearchPsychedelic research is coming to the University of California in a new division to study MDMA.